The discussion followed the development of the PHA technology of Paques Biomaterials as a case study, and covered the biggest scale-up challenges, how to resolve those, and the financial instruments in Europe.
Subscribe Now!
This content is only available to paid subscribers. Buy a subscription today. More Info